Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----[1] 309
2(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----[1] 309
3Brivaracetam[1] Brivaracetam[1] D08879 [1] SV2A 💬[1] ECM-receptor interaction 💬[2] 149, 309
4Brivaracetam 25 mg[1] Brivaracetam[1] D08879 [1] SV2A 💬[1] ECM-receptor interaction 💬[1] 309
5Brivaracetam 50 mg[1] Brivaracetam[1] D08879 [1] SV2A 💬[1] ECM-receptor interaction 💬[1] 309
6BRV 2.5 mg----[1] 309
7BRV 25 mg----[1] 309
8BRV 50 mg----[1] 309
9Intravenous Immunoglobulin----[8] 13, 14, 35, 38, 39, 49, 51, 309
10REQUIP[1] Ropinirole[2] D00784 ,
D08489 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309
11ROPINIROLE[1] Ropinirole[2] D00784 ,
D08489 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[3] 6, 74, 309
12Ropinirole Hydrochloride[1] Ropinirole[2] D00784 ,
D08489 		[3] DRD2,
DRD3,
DRD4 💬		[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 309
13Ucb 34714----[2] 149, 309